SaveHealth explores what the research says about Ozempic's effects on insulin resistance and related conditions.

A new study conducted by researchers at USC’s Keck School of Medicine explored a popular artificial sweetener – sucralose. ...

Use of cutting-edge weight-loss drugs like Ozempic and Zepbound has increased dramatically among people with type 1 diabetes, raising safety concerns among experts, a new study says.

Key Takeaways More people with type 1 diabetes are severely obese and using GLP-1 drugs for weight lossExperts are concerned ...

Novo Nordisk has experienced a 50% drop due to potential tariffs and recent clinical trial results. Read why I rate NVO stock a strong buy right now.

Sucralose increases hypothalamic activity linked to hunger more than sugar or water, especially in women and people with ...

A new study, conducted by researchers at the Keck School of Medicine USC, reveals that consuming sucralose activates the ...

Ozempic is a glucagon-like peptide-1 (GLP-1) receptor agonist. GLP-1 is a hormone that plays a vital role in glucose metabolism by: Stimulating insulin secretion when blood sugar levels are high ...

A new study found that a popular zero-calorie sugar substitute disrupts regions of the brain responsible for regulating ...

A new USC study reveals that sucralose, a popular artificial sweetener, may trick the brain by triggering hunger-related ...

Flavonoids show promise in treating type 2 diabetes mellitus by targeting the enteroendocrine system and regulating key gut ...

As a diabetes medication, GLP-1s are able to treat insulin resistance, something that many people with PCOS deal with. “It’s ...